跳至主要内容
临床试验/NCT07046000
NCT07046000尚未招募不适用

Magnetic Resonance Imaging (MRI) Evaluation of Graft Maturation Following Anterior Cruciate Ligament (ACL) Reconstruction With a Connective Tissue Allograft

Skye Biologics Holdings, LLC2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2026年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
10
试验地点
2
主要终点
Graft Maturation via MRI

研究概览

简要总结

Post-surgical ACL Graft maturation will be assessed at 4.5, 6, 7.5, 9, 10.5, and 12 months with MRI.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
14 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •ACL tear and reconstruction; no other knee ligaments needing reconstruction
  • •Primary (first-time) ACL tear in the affected knee
  • •ACL injury occurred less than 12 months before ACL reconstruction
  • •Have no contraindications or allergies to the treatment administered
  • •Have current imaging studies (plain radiographs and MRI exams within the past 12 months) of the knee to rule out other etiologic diagnoses
  • •Patient underwent ACL reconstruction with a Bone-Patellar Tendon-Bone (BTB) graft harvested from the same knee (ipsilateral autograft) with the Active Matrix tissue
  • •Able and willing to comply with the post-operative study follow-up schedule

排除标准

  • •Prior surgery on the index knee within 12 months of enrollment
  • •Steroid injection into the index knee within 6 weeks of enrollment
  • •Chronic ACL tear whereas the injury occurred more than 12 months ago
  • •Multiligamentous injuries whereas any ligament (MCL, PCL, or PLC) in addition to the ACL needs to be reconstructed
  • •Patient underwent ACL reconstruction with a hamstring tendon, Achilles tendon or quadriceps tendon graft (any graft other than a patellar tendon BTB)
  • •Contraindication to MRI (eg, implanted devices incompatible with MRI).
  • •Chrondral lesion of the knee that requires treatment during ACL reconstruction surgery
  • •History of advanced osteoarthritis of the knee or patella-femoral joint; KL grade III or higher
  • •History of malignant tumor and osseous metastatic disease,
  • •History of chronic pain disorders (i.e., fibromyalgia),
  • •Current substance abuse (drug or alcohol), by the investigator's judgment,
  • •Females who are pregnant, nursing or breastfeeding, or who intend to become pregnant during participation in the study.
  • •Currently participating in, or have been recently exited from (within 30 days from enrollment in this study), or plan to enroll in another clinical study for a bone allograft or drug that may impact participation or outcomes of this study,
  • •Currently involved in any injury litigation or workers compensation claims,
  • •Has a condition, disorder or other factor that, in the investigator's opinion, would interfere with study participation.

研究组 & 干预措施

ACL Reconstruction with Allograft

Subjects who have undergone ACL reconstruction with allograft

干预措施: MRI (Diagnostic Test)

结局指标

主要结局

Graft Maturation via MRI

时间窗: From 4.5 months post surgery until 12 months or graft maturation.

The signal to noise ratio will be calculated at the proximal, mid-substance, and distal positions of the graft

次要结局

未报告次要终点

研究者

发起方
Skye Biologics Holdings, LLC
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验